Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

Currently, the analyst consensus on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H is a Strong Buy with an average price target of HK$39.27.

Based on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of HK$375.38 million and a GAAP net loss of HK$136.31 million. In comparison, last year the company earned a revenue of HK$158.01 million and had a GAAP net loss of HK$365.25 million